stars 1 stars 2 stars 3

Headquartered in San Diego, California, Medipacs is focused on commercializing the first non-mechanical infusion pump based on a new, expandable polymer. The Medipacs novel polymer technology enables drug infusion pumps that are wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost. Market observers refer to miniature, wearable infusion pumps using terms like patch pump, wearable injectors and mini-infuser. The Medipacs infusion pump can be used to deliver drugs that are currently transfused or injected including biologic medications, insulin, hormones, fertility drugs, anti-coagulation drugs and pain medication. Traditional methods of delivering these drugs can be expensive, complicated, inconvenient and uncomfortable because they require significant nurse time and complex capital equipment; are prone to infection and medical errors; and require multiple needle sticks. Medipacs' senior management team, Board of Directors and team of advisors have extensive experience and successful track records introducing novel medical devices and infusion systems that have created meaningful business franchises and established significant value for physicians, patients, employees and shareholders.

Medipacs Questions

The Medipacs annual revenue was $13 million in 2026.

6 people are employed at Medipacs.

Medipacs is based in Tucson, Arizona.

The NAICS codes for Medipacs are [42, 4242, 42421, 424].

The SIC codes for Medipacs are [51, 512].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users